| Literature DB >> 35207598 |
Lorenzo Massimo Oldrini1, Pietro Feltri1, Jacopo Albanese1, Francesco Marbach1, Giuseppe Filardo1,2, Christian Candrian1,2.
Abstract
PURPOSE: The aim of this study was to quantify the rate of complications and reinterventions in patients treated with PHILOS plate for proximal humerus fractures (PHFs) synthesis.Entities:
Keywords: PHF; PHILOS; locking plate; osteosynthesis; proximal humeral fracture
Year: 2022 PMID: 35207598 PMCID: PMC8880552 DOI: 10.3390/life12020311
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Figure 1P.R.I.S.M.A. (Preferred Reporting Items for Systematic Meta-Analyses) flowchart of the study selection process. Assessment of risk of bias and quality of evidence.
Details of the included studies; Pt. patients, M male, F female, N Neer Classification, DS delto-split, DP delto-pectoral.
| First Author; Year | Country | Comparative | Pt. (M−F) | Age | Neer Classification | Mean | Surgical | ||
|---|---|---|---|---|---|---|---|---|---|
| N2 | N3 | N4 | |||||||
| Acklin et al., 2009 | Switzerland | NO | 29 (9−20) | 64 | N/A | N/A | N/A | 12 | DS |
| Acklin et al., 2013 | Switzerland | NO | 97 (N/A) | 62 | N/A | N/A | N/A | 18 | DS |
| Aggarwal et al., 2010 | India | NO | 47 (27−20) | 58.5 | 11 | 22 | 14 | 21.5 | DP |
| Aliuddin et al., 2016 | Pakistan | NO | 20 (12−8) | 40 | 4 | 10 | 6 | 6 | DP |
| Bachelier et al., 2014 | Germany | NO | 50 (20−30) | 62.7 | 15 | 18 | 17 | 12 | DS |
| Bandalovic et al., 2014 | Croatia | NO | 67 (N/A) | N/A | N/A | N/A | N/A | 14.7 | DP/DS |
| Beeres et al., 2017 | Switzerland | YES | 282 (85−197) | 64 | 58 | 153 | 74 | 12.3 | DP/DS |
| Bhayana et al., 2021 | India | YES | 84 (45−39) | 45 | 0 | 40 | 44 | 23 | DP/DS |
| Björkenheim et al., 2004 | Finland | NO | 72 (28−44) | 67 | 38 | 22 | 12 | 12 | DP |
| Boesmueller et al., 2016 | Austria | NO | 154 (61−93) | 55.8 | 41 | 71 | 42 | 15.5 | DP |
| Borer et al., 2017 | Switzerland | YES | 62 (16−46) | 64 | 18 | 4 | 10 | 51 | DP/DS |
| Boudard et al., 2014 | France | YES | 33 (19−14) | 49.6 | 0 | 21 | 12 | 24.7 | DP |
| Bu et al., 2021 | China | YES | 48 (17−31) | 66.3 | 28 | 13 | 7 | 15.6 | DP |
| Buchmann et al., 2021 | Switzerland | YES | 198 (75−123) | 64.3 | N/A | N/A | N/A | 12 | DP/DS |
| Cai et al., 2012 | China | YES | 12 (1−11) | 72.4 | 0 | 0 | 12 | 24 | DP |
| Caliskan et al., 2019 | Turkey | YES | 45 (18−27) | 53.2 | 11 | 21 | 13 | 25 | DS |
| Cha et al., 2017 | South | YES | 32 (8−24) | 67.8 | 8 | 21 | 3 | 15 | DP |
| Chen et al., 2019 | China | YES | 112 (37−75) | 64.29 | 52 | 60 | 0 | 15 | DP |
| Chen et al., 2020 | Taiwan | YES | 35 (13−22) | 56.1 | 12 | 17 | 6 | 12 | DP |
| Cho et al., 2017 | South | NO | 39 (12−27) | 59 | 14 | 22 | 3 | 45 | DP |
| Cohen et al., 2009 | Brazil | NO | 26 (12−14) | 57 | 7 | 10 | 7 | 12 | DP |
| Davids et al., 2020 | USA | YES | 75 (N/A) | 59.9 | 40 | 35 | 0 | 17.6 | DP |
| Doshi et al., 2017 | India | NO | 53 (24−29) | 54.3 | 19 | 17 | 11 | 12 | DP |
| Erasmo et al., 2014 | Italy | NO | 81 (39−42) | 56 | 7 | 40 | 35 | 32 | DP |
| Falez et al., 2019 | Italy | NO | 76 (26−50) | 68.5 | 3 | 35 | 38 | 12 | DS |
| Faraj et al., 2011 | Netherlands | YES | 37 (N/A) | N/A | N/A | N/A | N/A | 29 | DS |
| Fattoretto et al., 2016 | Italy | NO | 55 (17−38) | 63.4 | 0 | 16 | 39 | 21.5 | DP/DS |
| Fazal et al., 2009 | UK | NO | 27 (6−21) | 56 | 13 | 12 | 2 | 13 | DP |
| Fraser et al., 2020 | Norway | YES | 60 (8−52) | 74.7 | 0 | 29 | 31 | 24 | DP |
| Geiger et al., 2010 | Germany | NO | 28 (8−20) | 60.7 | 8 | 12 | 8 | 25.2 | DP |
| George et al., 2021 | India | NO | 35 (25−10) | 52 | 12 | 21 | 14 | 6 | DP |
| Gonc et al., 2017 | Turkey | NO | 31 (12−19) | 58.4 | 4 | 14 | 13 | 12 | DS |
| Gracitelli et al., 2013 | Brazil | NO | 40 (12−28) | 61.8 | 16 | 22 | 2 | 12 | DP |
| Gracitelli et al., 2016 | Brazil | YES | 33 (8−25) | 66.4 | 16 | 17 | 0 | 12 | DP |
| Handschin et al., 2008 | Switzerland | NO | 31 (11−20) | 62 | 8 | 13 | 10 | 19 | DP |
| Hengg et al., 2019 | Austria | YES | 34 (5−29) | 76 | 5 | 17 | 12 | 12 | DP |
| Jaura et al., 2014 | India | YES | 30 (20−10) | 65 | 12 | 14 | 4 | 12 | DP |
| Klitscher et al., 2008 | Germany | NO | 30 (11−19) | 59 | 2 | 16 | 12 | 16.4 | DP |
| Koukakis et al., 2006 | Greece | NO | 20 (8−12) | 61.7 | 5 | 11 | 4 | 16.2 | DP |
| Kumar et al., 2014 | India | NO | 51 (35−16) | 38 | 8 | 15 | 23 | 30 | DP |
| Launonen et al., 2019 | UK | YES | 44 (3−41) | 82 | 44 | 0 | 0 | 24 | N/A |
| Lee et al., 2017 | South | YES | 31 (11−20) | 58.6 | 31 | 0 | 0 | 21 | N/A |
| Leonard et al., 2009 | Ireland | NO | 32 (9−23) | 61.6 | N/A | N/A | N/A | 14 | DP |
| Lorenz et al., 2020 | Austria | YES | 31 (N/A) | 59 | 0 | 12 | 19 | 12 | DP |
| LuC.I.ani et al., 2020 | Italy | YES | 26 (3−23) | 73 | 0 | 9 | 15 | 40 | DP |
| Martinez et al., 2009 | Spain | NO | 58 (31−27) | 61 | 0 | 33 | 25 | 15 | DP |
| MatejC.I.c et al., 2013 | Croatia | NO | 59 (9−50) | 70.5 | 0 | 32 | 27 | 19 | DP |
| Miyazaki et al., 2012 | Brazil | NO | 56 (19−37) | 62 | 13 | 28 | 8 | 12 | DP |
| Monteiro et al., 2011 | Brazil | NO | 33 (14−19) | 57 | 17 | 13 | 4 | 24 | DP |
| Moonot et al., 2007 | UK | NO | 32 (9−23) | 59.9 | 0 | 20 | 12 | 11 | DP |
| Norouzi et al., 2012 | Iran | NO | 37 (27−10) | 50.1 | 13 | 20 | 4 | 12 | N/A |
| Ockert et al., 2014 | Germany | NO | 43 (12−31) | 58.2 | N/A | N/A | N/A | 120 | DP |
| Oh et al., 2015 | Germany | NO | 26 (6−20) | 67 | 0 | 17 | 9 | 20.1 | DS |
| Olerud et al., 2010 | Sweden | NO | 50 (10−40) | 75 | 50 | 0 | 0 | N/A | DP |
| Ortmaier et al., 2015 | Austria | YES | 30 (13−17) | 31.3 | 0 | 10 | 20 | 38.4 | N/A |
| Papadopoulos et al., 2009 | Greece | NO | 29 (12−17) | 62.3 | 0 | 22 | 7 | 17.9 | DP |
| Parmaksizoglu et al., 2010 | Turkey | NO | 32 (10−22) | 63 | 0 | 12 | 20 | 25 | DP |
| Plath et al., 2019 | Germany | YES | 32 (7−25) | 77.1 | 4 | 24 | 4 | 12.8 | DP/DS |
| Prajapati et al., 2020 | India | YES | 20 (5−15) | 41 | N/A | N/A | N/A | 12 | DP/DS |
| Robinson et al., 2010 | Scotland | NO | 47 (21−26) | 57 | 27 | 12 | 8 | 24 | DS |
| Seo et al., 2020 | South | NO | 27 (12−15) | 53 | 5 | 14 | 8 | 15.9 | DP |
| Setaro et al., 2020 | Italy | YES | 64 (N/A) | 61.5 | 37 | 27 | 0 | 48 | DP |
| Shahid et al., 2008 | UK | NO | 41 (9−32) | N/A | 11 | 11 | 19 | 12 | DP |
| Shi et al., 2011 | China | NO | 43 (15−28) | 68.7 | 10 | 21 | 12 | 12 | DP |
| Shin et al., 2021 | South | NO | 56 (12−44) | 74.3 | 21 | 27 | 8 | 15.4 | DP |
| Siebenbürger et al., 2019 | Germany | YES | 55 (12−43) | 76.6 | 20 | 22 | 13 | 24 | DP |
| Sohn et al., 2017 | South | YES | 90 (N/A) | 61.8 | 35 | 44 | 11 | 14.7 | DP/DS |
| Spross et al., 2012 | Switzerland | YES | 22 (4−18) | 75 | N/A | N/A | N/A | 30 | DP |
| Spross et al., 2012 | Switzerland | NO | 294 (71−223) | 72.9 | N/A | N/A | N/A | 12 | DP |
| Trepat et al., 2012 | Spain | YES | 11 (3−8) | 68.3 | 11 | 0 | 0 | 6 | DP |
| Urda et al., 2012 | Spain | NO | 15 (3−12) | 71 | 15 | 0 | 0 | 40.67 | DP |
| Vijan et al., 2020 | India | YES | 15 (N/A) | 52.3 | 7 | 6 | 2 | 12 | N/A |
| Vijayvargiya et al., 2016 | India | NO | 26 (19−7) | 46 | 5 | 12 | 9 | 12 | DS |
| Voigt et al., 2011 | Germany | YES | 31 (N/A) | 72 | 0 | 27 | 4 | 12 | DP |
| Wang et al., 2019 | China | YES | 46 (13−33) | 72.5 | 0 | 0 | 46 | 19 | DP |
| Xue et al., 2018 | China | YES | 43 (N/A) | 57 | 43 | 0 | 0 | N/A | DS |
| Zeng et al., 2018 | China | YES | 181 (64−117) | 57.4 | 78 | 75 | 28 | 12 | DP |
| Zhao et al., 2019 | China | YES | 21 (12−9) | 69 | 0 | 15 | 6 | 12 | DP |
Complication type; n° and rate of complications.
| Complication Type | N° of Complications | Complication Rate | % of the Total |
|---|---|---|---|
| Total complications | 1229 | 29.1 | 100% |
| Cut-out | 313 | 7.5 | 25.7% |
| AVN | 215 | 5.1 | 17.6% |
| Subacromial Impingement | 121 | 2.9 | 9.9% |
| Non-union | 79 | 1.9 | 6.4% |
| Fixation Loss | 76 | 1.8 | 6.3% |
| Pain | 70 | 1.6 | 5.7% |
| Others | 65 | 1.5 | 5.3% |
| Varus collapse | 45 | 1.1 | 3.6% |
| Stiffness | 41 | 0.9 | 3.1% |
| Deep Infection | 34 | 0.8 | 2.8% |
| Malunion | 36 | 0.8 | 2.9% |
| Nerve Injury | 30 | 0.7 | 2.4% |
| Failure | 20 | 0.5 | 1.6% |
| Superficial Infection | 15 | 0.4 | 1.2% |
| Malreduction | 14 | 0.3 | 1.2% |
| Screw-back | 7 | 0.2 | 0.6% |
| Plate Breaking | 4 | 0 | 0.3% |
| Unknown | 42 | 1 | 3.4% |
Figure 2Complications and reinterventions causes; data reported as percentages of the total complications and reinterventions.
Reasons for reintervention; n° and rate of reinterventions.
| Reintervention Reason | N ° of Reinterventions | Reintervention Rate | % of the Total |
|---|---|---|---|
| Total Reintervention | 514 | 16 | 100 |
| Cut-out | 69 | 2.2 | 13.4 |
| AVN | 61 | 1.9 | 11.9 |
| Subacromial Impingement | 53 | 1.7 | 10.3 |
| Pt will | 37 | 1.2 | 7.2 |
| Failure | 18 | 0.6 | 3.5 |
| Loss Fixation | 17 | 0.5 | 3.3 |
| Deep Infection | 13 | 0.4 | 2.5 |
| Non-Union | 10 | 0.3 | 2.0 |
| Pain | 8 | 0.2 | 1.6 |
| Varus Collapse | 8 | 0.2 | 1.6 |
| Other | 8 | 0.2 | 1.6 |
| Mal Reduction | 7 | 0.2 | 1.5 |
| Stiffness | 5 | 0.2 | 0.9 |
| Plate Discomfort | 5 | 0.2 | 0.9 |
| Malunion | 2 | 0 | 0.4 |
| Frozen Shoulder | 2 | 0 | 0.4 |
| Screw Back | 2 | 0 | 0.4 |
| Nerve Injury | 1 | 0 | 0.2 |
| Plate Break | 1 | 0 | 0.2 |
| Unknown | 187 | 5.8 | 36.2 |
Probability of reintervention for type of complication.
| Type of Complications | % of Complication Causing Reintervention |
|---|---|
| Cut-out | 32.5 |
| AVN | 35.9 |
| Subacromial impingement | 73.6 |
| Pain | 8.4 |
| Loss fixation | 56.5 |
| Non-union | 26.3 |
| Other | 25.0 |
| Varus collapse | 25.8 |
| Deep infection | 33.3 |
| Malunion | 8.0 |
| Stiffness | 27.8 |
| Nerve injury | 10 |
| Malreduction | 87.5 |
| Superficial infection | 0.0 |
| Screw-back | 0.0 |
| Plate breaking | 100 |
Details Pt with Complications and Reintervention.
| Pt. with Complications | N° of Complications | Complications Rate | Pt. with Reintervention | N° of Reintervention | Reintervention Rate | |
|---|---|---|---|---|---|---|
| >55 years | 836 | 347 | 29.5 | 761 | 216 | 19.0 |
| DP group | 2910 | 810 | 23.8 | 2301 | 291 | 8.6 |
| DS group | 657 | 137 | 17.5 | 398 | 53 | 10.4 |
| Pt. tot | 4200 | 1229 | 23.8 | 3210 | 514 | 10.5 |
Complication rate normalized for the type of fracture and surgical approach.
| Complication Rate | Neer Type 2 | Neer Type 3 | Neer Type 4 |
|---|---|---|---|
| DP group | 10.1 ± 2.8% | 13.5 ± 2.9% | 24.1 ± 3.8% |
| DS group | 8.5 ± 3.0% | 16.2 ± 7.0% | 25.6 ± 7.0% |
| 0.37 | 0.37 | 0.39 |
Figure 3Downs and Black’s tool for assessing the risk of bias. For the explanation of each column question, see Appendix A.